TFX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TFX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Teleflex's total current assets for the quarter that ended in Dec. 2023 was $1,407 Mil.
The historical data trend for Teleflex's Total Current Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teleflex Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Total Current Assets | Get a 7-Day Free Trial | 1,306.33 | 1,422.43 | 1,429.12 | 1,410.98 | 1,407.41 |
Teleflex Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Total Current Assets | Get a 7-Day Free Trial | 1,410.98 | 1,428.05 | 1,445.80 | 2,097.27 | 1,407.41 |
Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.
Teleflex's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as
Total Current Assets | = | Cash, Cash Equivalents, Marketable Securities | + | Total Receivables | + | Total Inventories | + | Other Current Assets |
= | 222.848 | + | 443.467 | + | 626.216 | + | 114.875 | |
= | 1,407 |
Teleflex's Total Current Assets for the quarter that ended in Dec. 2023 is calculated as
Total Current Assets | = | Cash, Cash Equivalents, Marketable Securities | + | Total Receivables | + | Total Inventories | + | Other Current Assets |
= | 222.848 | + | 443.467 | + | 626.216 | + | 114.875 | |
= | 1,407 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.
Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.
Teleflex (NYSE:TFX) Total Current Assets Explanation
In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.
Teleflex's Liquidation Value for the quarter that ended in Dec. 2023 is
Liquidation value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 222.848 | - | 3091.558 | + | 0.75 * 443.467 | + | 0.5 * 626.216 |
= | -2,223 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Teleflex's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Liam Kelly | officer: EVP & President, International | IDA BUSINESS AND TECHNOLOGY PARK, DUBLIN ROAD, ATHLONE L2 00000 |
Thomas E Powell | officer: Senior Vice President & CFO | C/O TOMOTHERAPY INCORPORATED, 1240 DEMING WAY, MADISON WI 53717 |
Stuart A Randle | director | 585 WEST 500 SOUTH, BOUNTIFUL UT 84010 |
Jaewon Ryu | director | 950 N. GLEBE ROAD, SUITE 700, ARLINGTON VA 22203 |
Neena M Patil | director | JAZZ PHARMACEUTICALS, 3170 PORTER DRIVE, PALO ALTO CA 94304 |
Andrew A Krakauer | director | CANTEL MEDICAL CORP., 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424 |
Cameron P Hicks | officer: Vice President, Global HR | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
Klasko Stephen K. M.d. | director | 155 SOUTH LIMERICK ROAD, LIMERICK PA 19468 |
Jay White | officer: VP & Pres, Global Commercial | 3015 CARRINGTON MILL BLVD., MORRISVILLE NC 27560 |
Daniel V. Logue | officer: VP, Gen Counsel & Secretary | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
John Deren | officer: VP & Chief Accounting Officer | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
James J Leyden | officer: VP, General Counsel, Secretary | C/O INFRASOURCE SERVICES, INC, 500 WEST DUTTON MILL ROAD, ASTON PA 19014 |
James Winters | officer: Vice President, Mfg and Supply | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
Mario Wijker | officer: Vice President, QARA | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
Benson Smith | director | C/O ROCHESTER MEDICAL INC, ONE ROCHESTER MEDICAL DDRIVE, STEWARTVILLE MN 55976 |
From GuruFocus
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.